PURPOSE Cisplatin is widely used and highly ototoxic, but patient-reported functional
impairment because of cisplatin-related hearing loss (HL) and tinnitus has not been …

Background No study has quantified the impact of pain and other adverse health outcomes
on global physical and mental health in long-term US testicular cancer survivors or …

Introduction The success in the management of germ cell tumors has encouraged
researchers to pay more attention on long-term side effects and other survivorship issues …

Purpose Ototoxicity is a prominent side effect of cisplatin-based chemotherapy. There are
few reports, however, estimating its prevalence in well-defined cohorts and associated risk …

Cancer, a potentially fatal condition, is one of the leading causes of death worldwide. Among
males aged 20 to 35, the most common cancer in healthy individuals is testicular cancer …

Importance Cisplatin is highly ototoxic but widely used. Evidence is lacking regarding
cisplatin-related hearing loss (CRHL) in adult-onset cancer survivors with comprehensive …

Cisplatin (CDDP) is broadly employed to treat different cancers, whereas there are no drugs
approved by the Food and Drug Administration (FDA) for preventing its side effects …

(1) Background: Milnacipran is a typical serotonin–norepinephrine reuptake inhibitor and
has been shown to have analgesic effects in several pain models. However, its …

Tinnitus is an unpleasant symptom characterized by detective hearing without the actual
sound input. Despite numerous studies elucidating a variety of pathomechanisms inducing …

A few cases of small fiber neuropathy (SFN) and tinnitus (TN) associated with coronavirus
disease 2019 have been reported. However, the relationship between SFN and TN has not …